Nephros

Nephros Years Dividend Increased

Years of Consecutive Dividend Increases of Nephros (NEPH) as of Nov 22, 2026.

Years Dividend Increased

-

Last updated:

Years of Consecutive Dividend Increases of Nephros is 2026 - . Years of Consecutive Dividend Increases of Nephros was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nephros Stock analysis

What does Nephros do? Nephros, Inc. generates revenue through its Water Filtration and Renal Products segments. The Water Filtration segment sells high-performance water purification filters for hospitals, healthcare facilities, dialysis centers, commercial facilities, military, and outdoor recreation markets. The Renal Products segment offers a second-generation hemodiafiltration system for end-stage renal disease patients. Products include ultrafiltration systems used in medical and commercial applications, with subsidiaries Biocon 1, LLC, Aether Water Systems, LLC, and Specialty Renal Products, Inc. supporting sales and development. The company's water filtration products are sold to hospitals, dialysis centers, and commercial facilities, while the hemodiafiltration system targets healthcare providers treating ESRD patients. Subsidiaries handle specialized development and distribution, ensuring market coverage across medical and commercial sectors. Revenue streams are derived from both segments, with products serving healthcare infrastructure and renal treatment needs. Nephros, Inc. focuses on medical device solutions for renal disease and water purification, leveraging its subsidiaries to expand market reach. The Water Filtration segment serves healthcare and commercial clients, while the Renal Products segment addresses ESRD treatment through advanced hemodiafiltration technology, creating a diversified revenue model. Nephros is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nephros stock

On Eulerpool you can find the complete historical development of Years of Consecutive Dividend Increases Nephros since 2006 – with annual values, charts, and detailed analysis.

This measures how many consecutive years the dividend has been raised. Companies with 25+ years are considered Dividend Aristocrats.

Years of Consecutive Dividend Increases's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Years of Consecutive Dividend Increases's Nephros historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Nephros

All Key Metrics — Nephros